WIA
GSK icon

Wetzel Investment Advisors’s GSK GSK Stock Holding History

Wetzel Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-381
Closed -$16.3K – 430
2024
Q2 		$16.3K Hold
381
– – 0.01% 377
2024
Q1 		$15K Hold
381
– – 0.01% 435
2023
Q4 		$14K Buy
+381
New +$13.7K 0.01% 440

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wetzel Investment Advisors's GSK Position: Q3 2024 in Review

Wetzel Investment Advisors sold out of GSK (GSK) in Q3 2024, closing a stake of 381 shares — an estimated $16.3K sold.

Wetzel Investment Advisors first reported a position in GSK in Q4 2023 and held it in 3 quarters. The position peaked at $16.3K in Q2 2024. 899 funds tracked by Wall St. Rank hold GSK as of Q3 2024.

  • Wetzel Investment Advisors reported no remaining GSK position as of Q3 2024 after selling out during the quarter.
  • Wetzel Investment Advisors sold 381 GSK shares in Q3 2024, an estimated $16.3K.
  • Wetzel Investment Advisors first reported a position in GSK in Q4 2023 and held it in 3 quarters.
  • Wetzel Investment Advisors's GSK position peaked at $16.3K in Q2 2024.
  • 899 funds tracked by Wall St. Rank held GSK as of Q3 2024.

Based on Wetzel Investment Advisors's 13F filing for Q3 2024, filed 29 Oct 2024.